Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Stefan H. Faderl"'
Autor:
Hagop M. Kantarjian, Elihu H. Estey, L. Austin Doyle, Steven M. Kornblau, Keith A. Baggerly, Wenbin Liu, Michael Andreeff, Jan A. Burger, LaKiesha Debose, Hongbo Lu, Jennie B. Feliu, Peter P. Ruvolo, Tapan M. Kadia, Xuelin Huang, Gautam Borthakur, Zhihong Zeng, Elias J. Jabbour, Stefan H. Faderl, Roland B. Walter, Marina Y. Konopleva
PDF file - 62KB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7674751f35affafe6019091815430c26
https://doi.org/10.1158/1078-0432.22450353.v1
https://doi.org/10.1158/1078-0432.22450353.v1
Autor:
Hagop M. Kantarjian, Elihu H. Estey, L. Austin Doyle, Steven M. Kornblau, Keith A. Baggerly, Wenbin Liu, Michael Andreeff, Jan A. Burger, LaKiesha Debose, Hongbo Lu, Jennie B. Feliu, Peter P. Ruvolo, Tapan M. Kadia, Xuelin Huang, Gautam Borthakur, Zhihong Zeng, Elias J. Jabbour, Stefan H. Faderl, Roland B. Walter, Marina Y. Konopleva
PDF file - 50KB, Correlation between RPPA and immunoblotting in samples from the patients treated on MK-2206 trial.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0b5b44254b7581e9f686bbaa95ef77d
https://doi.org/10.1158/1078-0432.22450359
https://doi.org/10.1158/1078-0432.22450359
Autor:
Hagop M. Kantarjian, Elihu H. Estey, L. Austin Doyle, Steven M. Kornblau, Keith A. Baggerly, Wenbin Liu, Michael Andreeff, Jan A. Burger, LaKiesha Debose, Hongbo Lu, Jennie B. Feliu, Peter P. Ruvolo, Tapan M. Kadia, Xuelin Huang, Gautam Borthakur, Zhihong Zeng, Elias J. Jabbour, Stefan H. Faderl, Roland B. Walter, Marina Y. Konopleva
PDF file - 131KB, Effects of MK-2206 on AKT signaling in FLT3-mutant AML cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51864edad1e7652a8a06876b4c9db637
https://doi.org/10.1158/1078-0432.22450368
https://doi.org/10.1158/1078-0432.22450368
Autor:
Hagop M. Kantarjian, Elihu H. Estey, L. Austin Doyle, Steven M. Kornblau, Keith A. Baggerly, Wenbin Liu, Michael Andreeff, Jan A. Burger, LaKiesha Debose, Hongbo Lu, Jennie B. Feliu, Peter P. Ruvolo, Tapan M. Kadia, Xuelin Huang, Gautam Borthakur, Zhihong Zeng, Elias J. Jabbour, Stefan H. Faderl, Roland B. Walter, Marina Y. Konopleva
PDF file - 145KB, The subtraction heat maps of selected markers in paired PB samples.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::216273ab9343c2cdd599a5bc61115df7
https://doi.org/10.1158/1078-0432.22450356
https://doi.org/10.1158/1078-0432.22450356
Autor:
Hagop M. Kantarjian, Elihu H. Estey, L. Austin Doyle, Steven M. Kornblau, Keith A. Baggerly, Wenbin Liu, Michael Andreeff, Jan A. Burger, LaKiesha Debose, Hongbo Lu, Jennie B. Feliu, Peter P. Ruvolo, Tapan M. Kadia, Xuelin Huang, Gautam Borthakur, Zhihong Zeng, Elias J. Jabbour, Stefan H. Faderl, Roland B. Walter, Marina Y. Konopleva
PDF file - 60KB, MK-2206 promotes accumulation of OCI-AML3 cells in the G1 phase of the cell cycle.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16c9996580deef2cab1d6a682f076c58
https://doi.org/10.1158/1078-0432.22450362.v1
https://doi.org/10.1158/1078-0432.22450362.v1
Autor:
Hagop M. Kantarjian, Elihu H. Estey, L. Austin Doyle, Steven M. Kornblau, Keith A. Baggerly, Wenbin Liu, Michael Andreeff, Jan A. Burger, LaKiesha Debose, Hongbo Lu, Jennie B. Feliu, Peter P. Ruvolo, Tapan M. Kadia, Xuelin Huang, Gautam Borthakur, Zhihong Zeng, Elias J. Jabbour, Stefan H. Faderl, Roland B. Walter, Marina Y. Konopleva
Purpose: Recent studies suggested that AKT activation might confer poor prognosis in acute myelogenous leukemia (AML), providing the rationale for therapeutic targeting of this signaling pathway. We, therefore, explored the preclinical and clinical a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d69db895e26caec4ada75179514f23c2
https://doi.org/10.1158/1078-0432.c.6521913
https://doi.org/10.1158/1078-0432.c.6521913
The new edition of this well-received book provides a timely update of current knowledge on the biology, disease classification, and treatment of the acute leukemias – acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Throughout,
Autor:
Srdan Verstovsek, Jianqin Shan, William G. Wierda, Jorge E. Cortes, Emil J. Freireich, Susan O'Brien, Moshe Talpaz, Francis J. Giles, R N Mary Beth Rios, Hagop Kantarjian, Alessandra Ferrajoli, Michael J. Keating, Stefan H. Faderl
Publikováno v:
Cancer. 97:1033-1041
BACKGROUND Little is known regarding long-term prognosis among patients with Philadelphia chromosome (Ph)-positive chronic myelogenous leukemia (CML) who achieve a complete cytogenetic response (0% Ph-positive cells) after treatment with interferon-
Autor:
Elias Jabbour, Koji Sasaki, Naval Daver, Naveen Pemmaraju, Nitin Jain, Tapan M. Kadia, Courtney D. DiNardo, Gautam Borthakur, Marina Konopleva, Stefan H. Faderl, Susan O'Brien, Jorge Cortes, Hagop Kantarjian, Guillermo Garcia-Manero
Publikováno v:
Blood. 124:534-534
Background: Treatment with HMAs such as azacitidine and decitabine has changed the overall outcome of patients with MDS. Failure to respond to or relapse from HMA treatment is associated with poor prognosis without further approved therapy. Clofarabi
Autor:
Paolo Strati, Michael J. Keating, Susan O'Brien, Jan A. Burger, Alessandra Ferrajoli, Nitin Jain, Zeev Estrov, Jeffrey L. Jorgensen, Stefan H. Faderl, William G. Wierda
Publikováno v:
Blood. 122:1621-1621
Background Minimal Residual Disease (MRD) status at end of first-line chemoimmunotherapy is an independent prognostic factor for patients (pts) with chronic lymphocytic leukemia (CLL). In the CLL8 trial of the German CLL Study Group, peripheral blood